Insmed Inc. buy Guggenheim
Start price
18.12.25
/
50%
€142.00
Target price
18.12.26
€188.27
Performance (%)
-24.56%
Price
20.08.26
?
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -24.56%. This prediction currently runs until 18.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.400% | -3.400% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Guggenheim from $230.00 to $221.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat